Shares of Orthofix International N.V. (NASDAQ:OFIX) have been given a consensus rating of “Buy” by the eight research firms that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $53.30.

OFIX has been the subject of several recent research reports. BidaskClub lowered shares of Orthofix International N.V. from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 25th. Zacks Investment Research raised shares of Orthofix International N.V. from a “hold” rating to a “buy” rating and set a $54.00 price objective on the stock in a research report on Thursday, August 10th. TheStreet raised shares of Orthofix International N.V. from a “c+” rating to a “b-” rating in a research report on Tuesday, August 8th. Jefferies Group LLC reaffirmed a “buy” rating and issued a $55.00 price objective (up previously from $50.00) on shares of Orthofix International N.V. in a research report on Thursday, August 10th. Finally, BTIG Research set a $56.00 price objective on shares of Orthofix International N.V. and gave the stock a “buy” rating in a research report on Monday, October 30th.

COPYRIGHT VIOLATION WARNING: This story was originally reported by Watch List News and is owned by of Watch List News. If you are viewing this story on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this story can be viewed at https://www.watchlistnews.com/orthofix-international-n-v-ofix-receives-average-recommendation-of-buy-from-analysts/1699025.html.

In other Orthofix International N.V. news, CFO Rice Doug sold 7,353 shares of the business’s stock in a transaction that occurred on Monday, September 11th. The shares were sold at an average price of $49.46, for a total transaction of $363,679.38. Following the sale, the chief financial officer now owns 44,743 shares of the company’s stock, valued at approximately $2,212,988.78. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Brad Mason sold 2,733 shares of the business’s stock in a transaction that occurred on Monday, August 21st. The stock was sold at an average price of $48.10, for a total transaction of $131,457.30. Following the sale, the chief executive officer now directly owns 188,053 shares in the company, valued at approximately $9,045,349.30. The disclosure for this sale can be found here. In the last ninety days, insiders sold 21,842 shares of company stock worth $1,084,897. Insiders own 5.60% of the company’s stock.

Large investors have recently added to or reduced their stakes in the business. Paradice Investment Management LLC purchased a new stake in Orthofix International N.V. during the 2nd quarter worth approximately $6,642,000. NorthCoast Asset Management LLC grew its position in Orthofix International N.V. by 26.9% during the 2nd quarter. NorthCoast Asset Management LLC now owns 92,952 shares of the medical device company’s stock worth $4,320,000 after purchasing an additional 19,691 shares during the last quarter. Blair William & Co. IL purchased a new stake in Orthofix International N.V. during the 2nd quarter worth approximately $1,301,000. OppenheimerFunds Inc. purchased a new stake in shares of Orthofix International N.V. in the 1st quarter valued at $305,000. Finally, California Public Employees Retirement System boosted its holdings in shares of Orthofix International N.V. by 4.8% in the 1st quarter. California Public Employees Retirement System now owns 61,400 shares of the medical device company’s stock valued at $2,342,000 after acquiring an additional 2,800 shares during the last quarter. 93.81% of the stock is currently owned by institutional investors.

Shares of Orthofix International N.V. (OFIX) opened at $51.44 on Monday. Orthofix International N.V. has a twelve month low of $32.51 and a twelve month high of $54.33. The company has a market cap of $937.80, a PE ratio of 33.62, a PEG ratio of 2.55 and a beta of 0.15.

Orthofix International N.V. (NASDAQ:OFIX) last posted its quarterly earnings results on Monday, October 30th. The medical device company reported $0.42 EPS for the quarter, beating the consensus estimate of $0.41 by $0.01. Orthofix International N.V. had a net margin of 0.33% and a return on equity of 10.26%. The business had revenue of $105.30 million during the quarter, compared to analyst estimates of $100.67 million. During the same quarter in the previous year, the business posted $0.36 EPS. The company’s quarterly revenue was up 6.9% compared to the same quarter last year. equities analysts forecast that Orthofix International N.V. will post 1.61 earnings per share for the current year.

About Orthofix International N.V.

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.

Analyst Recommendations for Orthofix International N.V. (NASDAQ:OFIX)

Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.